Health Care & Life Sciences » Pharmaceuticals | YiChang HEC ChangJiang Pharmaceutical Co. Ltd.

YiChang HEC ChangJiang Pharmaceutical Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
41
139
1,665
1,622
1,481
677
Total Accounts Receivable
762
204
302
370
883
1,135
Inventories
289
250
193
130
120
224
Other Current Assets
9
4
-
-
-
-
Total Current Assets
1,101
598
2,160
2,121
2,483
2,036
Net Property, Plant & Equipment
987
580
452
462
899
1,481
Intangible Assets
-
-
-
-
540
655
Other Assets
29
2
452
563
576
993
Total Assets
2,124
1,187
3,076
3,159
4,533
5,201
ST Debt & Current Portion LT Debt
858
432
128
81
12
Accounts Payable
48
36
37
22
66
Income Tax Payable
8
11
7
31
92
Other Current Liabilities
54
78
151
184
598
Total Current Liabilities
967
557
324
317
769
Long-Term Debt
433
181
107
22
12
Deferred Taxes
7
7
12
13
34
Other Liabilities
-
-
-
-
78
Total Liabilities
1,401
739
431
339
859
Common Equity (Total)
613
347
2,558
2,742
3,371
Total Shareholders' Equity
613
347
2,558
2,742
3,371
Total Equity
613
347
2,558
2,742
3,674
Liabilities & Shareholders' Equity
2,124
1,187
3,076
3,159
4,533
Accumulated Minority Interest
-
-
-
-
303
Non-Equity Reserves
110
102
88
77
-

About YiChang HEC ChangJiang Pharmaceutical Co.

View Profile
Address
Dong YangGuang Park
Dongguan Guangdong 443300
China
Employees -
Website http://www.hec-changjiang.com
Updated 07/08/2019
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. engages in the development, manufacturing and selling of pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases, cardiovascular diseases and others. Its products include Benzbromarone, Telmisartan, Amlodipine besylate, and Cetirizine hydrochloride. The company was founded on May 11, 2015 and is headquartered in Dongguan, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.